Encyclopedia of Chemistry

Target:
Operation:
Search for:

Overview Complete alphabetical index  
Vandetanib

Vandetanib
Systematic (IUPAC) name
N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-
[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
Identifiers
CAS number 443913-73-3
ATC code  ?
PubChem 3081361
Chemical data
Formula C22H24BrFN4O2 
Mol. mass 475.354 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 days (mean)
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Vandetanib (rINN, trade name Zactima), also known as ZD6474, is a medication currently undergoing clinical trials as a potential targeted treatment for non–small-cell lung cancer. It is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR).

Vandetanib is being developed by AstraZeneca.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Vandetanib". A list of authors is available in Wikipedia.
MyChemEurope.COM
Newsletter Subscription
Your e-mail:
Top  
© 2006-2009 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Bionity.COM   www.ChemEurope.COM   www.Quimica.ES   www.ChemieKarriere.NET   www.BioKarriere.NET